CYTK logo

CYTK EBIT

annual EBIT:

-$503.01M-$34.44M(-7.35%)
December 31, 2024

Summary

  • As of today (July 1, 2025), CYTK annual earnings before interest & taxes is -$503.01 million, with the most recent change of -$34.44 million (-7.35%) on December 31, 2024.
  • During the last 3 years, CYTK annual EBIT has fallen by -$317.03 million (-170.46%).
  • CYTK annual EBIT is now -2103.80% below its all-time high of $25.10 million, reached on December 31, 2009.

Performance

CYTK EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCYTKincome statement metrics

quarterly EBIT:

-$138.43M-$11.00M(-8.64%)
March 1, 2025

Summary

  • As of today (July 1, 2025), CYTK quarterly earnings before interest & taxes is -$138.43 million, with the most recent change of -$11.00 million (-8.64%) on March 1, 2025.
  • Over the past year, CYTK quarterly EBIT has dropped by -$20.11 million (-16.99%).
  • CYTK quarterly EBIT is now -346.89% below its all-time high of $56.07 million, reached on June 30, 2009.

Performance

CYTK quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCYTKincome statement metrics

TTM EBIT:

-$523.12M-$20.11M(-4.00%)
March 1, 2025

Summary

  • As of today (July 1, 2025), CYTK TTM earnings before interest & taxes is -$523.12 million, with the most recent change of -$20.11 million (-4.00%) on March 1, 2025.
  • Over the past year, CYTK TTM EBIT has dropped by -$54.27 million (-11.58%).
  • CYTK TTM EBIT is now -2040.87% below its all-time high of $26.95 million, reached on September 30, 2009.

Performance

CYTK TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCYTKincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

CYTK EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-7.3%-17.0%-11.6%
3 y3 years-170.5%-72.8%-131.7%
5 y5 years-433.2%-364.2%-393.1%

CYTK EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-170.5%at low-1282.9%at low-188.7%at low
5 y5-year-467.6%at low-2310.6%at low-580.1%at low
alltimeall time-2103.8%at low-346.9%at low-2040.9%at low

CYTK EBIT History

DateAnnualQuarterlyTTM
Mar 2025
-
-$138.43M(+8.6%)
-$523.12M(+4.0%)
Dec 2024
-$503.01M(+7.3%)
-$127.43M(-7.8%)
-$503.01M(+1.5%)
Sep 2024
-
-$138.25M(+16.2%)
-$495.42M(+4.8%)
Jun 2024
-
-$119.02M(+0.6%)
-$472.60M(+0.8%)
Mar 2024
-
-$118.32M(-1.3%)
-$468.85M(+0.1%)
Dec 2023
-$468.58M(+38.7%)
-$119.83M(+3.8%)
-$468.58M(-0.3%)
Sep 2023
-
-$115.43M(+0.1%)
-$469.86M(-2.3%)
Jun 2023
-
-$115.27M(-2.4%)
-$480.97M(+28.0%)
Mar 2023
-
-$118.05M(-2.5%)
-$375.71M(+11.2%)
Dec 2022
-$337.80M(+81.6%)
-$121.11M(-4.3%)
-$337.80M(+41.5%)
Sep 2022
-
-$126.54M(+1164.2%)
-$238.77M(+31.8%)
Jun 2022
-
-$10.01M(-87.5%)
-$181.20M(-19.8%)
Mar 2022
-
-$80.14M(+262.9%)
-$225.80M(+21.4%)
Dec 2021
-$185.98M(+109.9%)
-$22.08M(-68.0%)
-$185.98M(-6.1%)
Sep 2021
-
-$68.97M(+26.3%)
-$197.98M(+61.3%)
Jun 2021
-
-$54.61M(+35.4%)
-$122.75M(+23.8%)
Mar 2021
-
-$40.32M(+18.3%)
-$99.11M(+11.8%)
Dec 2020
-$88.61M(-6.1%)
-$34.08M(-644.2%)
-$88.61M(+15.2%)
Sep 2020
-
$6.26M(-120.2%)
-$76.91M(-27.5%)
Jun 2020
-
-$30.98M(+3.9%)
-$106.08M(+5.3%)
Mar 2020
-
-$29.82M(+33.3%)
-$100.78M(+6.8%)
Dec 2019
-$94.33M(+11.3%)
-$22.38M(-2.3%)
-$94.33M(+2.0%)
Sep 2019
-
-$22.91M(-10.8%)
-$92.51M(+7.3%)
Jun 2019
-
-$25.67M(+9.8%)
-$86.20M(+4.1%)
Mar 2019
-
-$23.38M(+13.7%)
-$82.81M(-2.3%)
Dec 2018
-$84.72M(-23.5%)
-$20.56M(+23.9%)
-$84.72M(-15.2%)
Sep 2018
-
-$16.59M(-25.6%)
-$99.92M(-10.0%)
Jun 2018
-
-$22.29M(-11.9%)
-$110.97M(-2.0%)
Mar 2018
-
-$25.29M(-29.3%)
-$113.27M(+2.2%)
Dec 2017
-$110.79M(-678.5%)
-$35.75M(+29.3%)
-$110.80M(+64.9%)
Sep 2017
-
-$27.64M(+12.5%)
-$67.17M(+1132.3%)
Jun 2017
-
-$24.58M(+7.7%)
-$5.45M(-166.3%)
Mar 2017
-
-$22.82M(-389.9%)
$8.23M(-57.0%)
Dec 2016
$19.15M(-151.4%)
$7.87M(-76.9%)
$19.15M(+725.8%)
Sep 2016
-
$34.08M(-412.5%)
$2.32M(-105.7%)
Jun 2016
-
-$10.90M(-8.3%)
-$40.61M(+0.8%)
Mar 2016
-
-$11.89M(+32.7%)
-$40.29M(+8.0%)
Dec 2015
-$37.23M(+154.2%)
-$8.96M(+1.3%)
-$37.31M(+88.3%)
Sep 2015
-
-$8.85M(-16.4%)
-$19.82M(+16.8%)
Jun 2015
-
-$10.59M(+18.9%)
-$16.97M(+14.8%)
Mar 2015
-
-$8.91M(-204.5%)
-$14.79M(+0.9%)
Dec 2014
-$14.65M(-56.6%)
$8.53M(-242.2%)
-$14.65M(-11.6%)
Sep 2014
-
-$6.00M(-28.7%)
-$16.57M(-28.5%)
Jun 2014
-
-$8.41M(-4.1%)
-$23.18M(-22.3%)
Mar 2014
-
-$8.77M(-232.7%)
-$29.84M(-11.5%)
Dec 2013
-$33.72M
$6.61M(-152.4%)
-$33.72M(-34.9%)
DateAnnualQuarterlyTTM
Sep 2013
-
-$12.61M(-16.3%)
-$51.78M(+5.2%)
Jun 2013
-
-$15.07M(+19.1%)
-$49.21M(+14.1%)
Mar 2013
-
-$12.65M(+10.4%)
-$43.12M(+6.7%)
Dec 2012
-$40.37M(-15.6%)
-$11.46M(+14.1%)
-$40.39M(-1.0%)
Sep 2012
-
-$10.04M(+12.0%)
-$40.81M(-1.4%)
Jun 2012
-
-$8.97M(-9.6%)
-$41.40M(-10.1%)
Mar 2012
-
-$9.93M(-16.4%)
-$46.05M(-3.7%)
Dec 2011
-$47.82M(-3.0%)
-$11.87M(+11.7%)
-$47.82M(+0.6%)
Sep 2011
-
-$10.63M(-21.9%)
-$47.54M(-3.8%)
Jun 2011
-
-$13.62M(+16.4%)
-$49.41M(+1.1%)
Mar 2011
-
-$11.70M(+0.9%)
-$48.88M(-0.9%)
Dec 2010
-$49.30M(-296.4%)
-$11.59M(-7.3%)
-$49.30M(-1.4%)
Sep 2010
-
-$12.50M(-4.4%)
-$49.99M(+9.7%)
Jun 2010
-
-$13.08M(+7.9%)
-$45.59M(-293.4%)
Mar 2010
-
-$12.12M(-1.4%)
$23.57M(-6.1%)
Dec 2009
$25.10M(-144.9%)
-$12.29M(+51.8%)
$25.10M(-6.9%)
Sep 2009
-
-$8.10M(-114.4%)
$26.95M(+29.4%)
Jun 2009
-
$56.07M(-629.7%)
$20.83M(-140.6%)
Mar 2009
-
-$10.59M(+1.4%)
-$51.28M(-8.2%)
Dec 2008
-$55.88M(-1.1%)
-$10.44M(-26.6%)
-$55.88M(-7.5%)
Sep 2008
-
-$14.22M(-11.3%)
-$60.41M(+1.7%)
Jun 2008
-
-$16.04M(+5.6%)
-$59.38M(+2.5%)
Mar 2008
-
-$15.19M(+1.6%)
-$57.91M(+2.5%)
Dec 2007
-$56.49M(-7.9%)
-$14.96M(+13.3%)
-$56.49M(-3.5%)
Sep 2007
-
-$13.20M(-9.4%)
-$58.51M(-4.6%)
Jun 2007
-
-$14.56M(+5.8%)
-$61.31M(-0.5%)
Mar 2007
-
-$13.76M(-18.9%)
-$61.63M(+0.5%)
Dec 2006
-$61.34M(+37.4%)
-$16.98M(+6.1%)
-$61.34M(+9.4%)
Sep 2006
-
-$16.00M(+7.5%)
-$56.05M(+10.4%)
Jun 2006
-
-$14.89M(+10.6%)
-$50.78M(+8.1%)
Mar 2006
-
-$13.47M(+15.2%)
-$46.99M(+5.3%)
Dec 2005
-$44.63M(+16.1%)
-$11.70M(+9.0%)
-$44.63M(-1.3%)
Sep 2005
-
-$10.73M(-3.4%)
-$45.23M(+0.2%)
Jun 2005
-
-$11.10M(-0.1%)
-$45.15M(+3.6%)
Mar 2005
-
-$11.11M(-9.6%)
-$43.57M(+13.4%)
Dec 2004
-$38.43M(+17.9%)
-$12.29M(+15.3%)
-$38.43M(-42.3%)
Sep 2004
-
-$10.65M(+11.9%)
-$66.67M(+24.9%)
Jun 2004
-
-$9.52M(+59.5%)
-$53.37M(+9.9%)
Mar 2004
-
-$5.97M(-85.3%)
-$48.58M(+2.0%)
Dec 2003
-$32.59M(+35.9%)
-$40.52M(-1632.6%)
-$47.62M(+571.1%)
Sep 2003
-
$2.64M(-155.9%)
-$7.09M(-27.1%)
Jun 2003
-
-$4.73M(-5.5%)
-$9.74M(+94.5%)
Mar 2003
-
-$5.01M
-$5.01M
Dec 2002
-$23.98M(+30.4%)
-
-
Dec 2001
-$18.39M(+33.3%)
-
-
Dec 2000
-$13.79M
-
-

FAQ

  • What is Cytokinetics Incorporated annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Cytokinetics Incorporated?
  • What is Cytokinetics Incorporated annual EBIT year-on-year change?
  • What is Cytokinetics Incorporated quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Cytokinetics Incorporated?
  • What is Cytokinetics Incorporated quarterly EBIT year-on-year change?
  • What is Cytokinetics Incorporated TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Cytokinetics Incorporated?
  • What is Cytokinetics Incorporated TTM EBIT year-on-year change?

What is Cytokinetics Incorporated annual earnings before interest & taxes?

The current annual EBIT of CYTK is -$503.01M

What is the all time high annual EBIT for Cytokinetics Incorporated?

Cytokinetics Incorporated all-time high annual earnings before interest & taxes is $25.10M

What is Cytokinetics Incorporated annual EBIT year-on-year change?

Over the past year, CYTK annual earnings before interest & taxes has changed by -$34.44M (-7.35%)

What is Cytokinetics Incorporated quarterly earnings before interest & taxes?

The current quarterly EBIT of CYTK is -$138.43M

What is the all time high quarterly EBIT for Cytokinetics Incorporated?

Cytokinetics Incorporated all-time high quarterly earnings before interest & taxes is $56.07M

What is Cytokinetics Incorporated quarterly EBIT year-on-year change?

Over the past year, CYTK quarterly earnings before interest & taxes has changed by -$20.11M (-16.99%)

What is Cytokinetics Incorporated TTM earnings before interest & taxes?

The current TTM EBIT of CYTK is -$523.12M

What is the all time high TTM EBIT for Cytokinetics Incorporated?

Cytokinetics Incorporated all-time high TTM earnings before interest & taxes is $26.95M

What is Cytokinetics Incorporated TTM EBIT year-on-year change?

Over the past year, CYTK TTM earnings before interest & taxes has changed by -$54.27M (-11.58%)
On this page